HEALTH
At the 39th African Union Summit in Ethiopia, leaders issued a stark warning: malaria progress is at risk. With 270 million cases reported in 2024—96% of the global total, the continent faces the possibility of losing decades of hard-won gains if financing falters.
The 2025 Africa Malaria Progress Report projected that a 30% reduction in funding could mean 146 million additional cases, nearly 400,000 more deaths (three-quarters of them children under five), and a staggering USD 37 billion loss in GDP by 2030.
Against this backdrop, African scientists are exploring innovative tools to complement existing measures like insecticide-treated nets, indoor spraying, vaccines, and medicines. One of the most promising and debated approaches is gene drive technology.
What is Gene Drive?
Gene drive is a natural biological process being harnessed to alter mosquito populations. By biasing inheritance, it ensures certain genetic traits spread rapidly through generations. Researchers are investigating two strategies: Reducing malaria-carrying mosquito populations, Blocking the parasite from infecting mosquitoes, Target Malaria, a consortium of African, European and North American institutions, focuses on reducing mosquito numbers. Importantly, the research targets only four species of Anopheles mosquitoes, the primary malaria vectors in Africa, not all 3,500 mosquito species worldwide.
Currently, gene drive mosquitoes exist only in controlled laboratories in Europe and the United States. None have been released in Africa. Strict biosafety laws, ethical reviews, and regulatory approvals govern every stage of research. Field trials in Africa are anticipated by 2030, but only after extensive risk assessments and community engagement.
Why Africa?
Malaria remains Africa’s deadliest disease for children under five and costs the continent an estimated USD 16 billion annually. Resistance to insecticides and drugs is undermining existing tools, while climate change could add 500,000 deaths and 123 million cases by 2050.
Gene drive offers a long-term, self-sustaining solution that directly targets malaria-transmitting species without reliance on insecticides. It is not a replacement but a complementary tool to strengthen malaria control.
As President Samia Suluhu Hassan of Tanzania emphasized, “This is African science, conducted by African researchers, addressing an African challenge.” Clear communication is vital. By answering questions openly, about safety, scope and purpose scientists build trust with communities, policymakers and journalists.
Gene drive may not be a silver bullet, but it represents a bold step in Africa’s fight against malaria a fight where innovation, transparency, and collaboration are as crucial as nets and medicines.
